HealthCore Inc., Wilmington, DE, USA.
J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):52-8. doi: 10.1331/JAPhA.2012.10195.
To determine the prevalence and predictors of human papillomavirus (HPV) vaccination in adolescent girls who were recommended to receive the vaccine by their health care providers.
Cross-sectional study.
United States in 2007-08.
Parents or guardians most knowledgeable about health and health care of adolescent girls aged 12 to 17 years participating in the 2007 National Survey of Children's Health (NSCH).
NCSH was a population-based telephone survey using a complex probability sampling design.
Prevalence of HPV vaccination in adolescent girls who were recommended to receive the HPV vaccine and predisposing, enabling, and need factors associated with HPV vaccination.
Of 12.38 million adolescent girls aged 12 to 17 years, 3.69 million (29.76%) were recommended to receive the HPV vaccine by their health care provider. The majority who received the HPV vaccine recommendation were 13 to 17 years of age (83%), were white (71%), and had one or more preventive visits (94%). Among those for whom the HPV vaccine was recommended, 48.75% (95% CI 45.37-52.13) received the vaccine. Multivariate logistic regression analysis of those who were recommended revealed that enabling and predisposing factors were significantly associated with the HPV vaccination. Children living at 101% to 200% of the Federal Poverty Level (odds ratio 0.54 [95% CI 0.30-0.98]) and children in households with two or more adults (0.51 [0.33-0.80]) were negatively associated with HPV vaccination, whereas children with any preventive medical care visit(s) (2.28 [1.36-3.84]) in the previous year were positively associated with HPV vaccination.
Nearly one-half of adolescent girls received the HPV vaccine among those who were recommended by their health care provider. The study finding emphasizes the importance of predisposing and enabling factors for HPV vaccination. Policy and education efforts can focus on these factors to improve HPV vaccination rates.
确定被医疗保健提供者推荐接种 HPV 疫苗的少女 HPV 疫苗接种的流行率和预测因素。
横断面研究。
2007-08 年美国。
参与 2007 年全国儿童健康调查（NSCH）的年龄在 12 至 17 岁的最了解青少年女孩健康和保健的父母或监护人。
NCSH 是一项基于人群的电话调查，采用复杂的概率抽样设计。
被医疗保健提供者推荐接种 HPV 疫苗的少女 HPV 疫苗接种的流行率以及与 HPV 疫苗接种相关的倾向、促成和需求因素。
在 1238 万 12 至 17 岁的少女中，有 369 万人（29.76%）被医疗保健提供者推荐接种 HPV 疫苗。接受 HPV 疫苗推荐的大多数人年龄在 13 至 17 岁（83%），是白人（71%），并且有一次或多次预防就诊（94%）。在被推荐接种 HPV 疫苗的人群中，有 48.75%（95%CI 45.37-52.13）接种了疫苗。对被推荐的人群进行多变量逻辑回归分析显示，促成和倾向因素与 HPV 疫苗接种显著相关。生活在联邦贫困线 101%至 200%的儿童（比值比 0.54 [95%CI 0.30-0.98]）和有两个或更多成年人的家庭的儿童（0.51 [0.33-0.80]）与 HPV 疫苗接种呈负相关，而在前一年有任何预防医疗保健就诊的儿童（2.28 [1.36-3.84]）与 HPV 疫苗接种呈正相关。
在被医疗保健提供者推荐接种 HPV 疫苗的少女中，近一半的人接种了 HPV 疫苗。研究结果强调了 HPV 疫苗接种的倾向和促成因素的重要性。政策和教育工作可以侧重于这些因素，以提高 HPV 疫苗接种率。
